3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
9
Rectal Neoplasms
4
Lymphoma, B-Cell, Marginal Zone
4
Surgical Wound Infection
3
Pancreatic Neoplasms
3
Lymphoma
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer
1
Postoperative Complications
1
Persistence of Infection With Helicobacter Pylori
1
Neutropenia
1
Neoplasms
1
Mouth Neoplasms
1
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
1
Lymphoma, Non-Hodgkin
1
Leukemia, B-Cell
1
Inflammatory Bowel Diseases
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
For Patients With Colorectal Cancer Liver Metastases Who Were Not Able to Curative Surgical Resection.Focused on the Treatment Effect With the Quintuple Method
1
Febrile Neutropenia
1
Familial primary gastric lymphoma
1
Dysbiosis
1
Diverticulitis
1
Colonic Neoplasms
1
Anastomotic Leak
1
Adenocarcinoma
1
Interventions
Tomography, X-Ray Computed
2
Serum Albumin, Human
2
Proctectomy
2
Indocyanine Green
2
Ileostomy
2
Esophagectomy
2
Colectomy
2
Bioseal
2
obsidian
1
Water
1
Tobramycin
1
Tissue Adhesives
1
Surgical Procedures, Operative
1
Surgical Fixation Devices
1
Stents
1
Somatostatin
1
Sodium Chloride
1
Saline Solution
1
Robotic Surgical Procedures
1
Proctoscopy
1
Neomycin
1
Neoadjuvant Therapy
1
Negative-Pressure Wound Therapy
1
Mortality
1
Metronidazole
1
Marital Status
1
Laparotomy
1
Inulin
1
Hematologic Tests
1
Fibrin Tissue Adhesive
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Anastomotic Leak
×
Metronidazole
×
Clear all
NCT02682485
2023-04-26
SES-DTA
University of Chicago
Phase 2
Withdrawn